A non-inferiority randomized controlled study of Perampanel versus Oxcarbazepine monotherapy for post-stroke epilepsy. Yan C, Liu J, Jiang J, Sun Y, et al. Seizure 2025;125:172-178.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yan C, Liu J, Jiang J, Sun Y, et al. A non-inferiority randomized controlled study of Perampanel versus Oxcarbazepine monotherapy for post-stroke epilepsy. Seizure 2025;125:172-178.
PMID: 39848108